Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amid Biosciences is a private U.S. life science tools company that develops and manufactures products and services for biomedical research rather than a therapeutic drug pipeline company. The company focuses on protein engineering and enzyme development, recombinant protein expression and purification, and gene cloning reagents and services. Its catalog and custom offerings include recombinant proteins, polymerases, cloning tools, competent cells, magnetic nanoparticles, and custom protein production services. Amid Biosciences emphasizes in-house manufacturing in Santa Clara, California, with support for academic, industrial, and government research customers. Based on publicly available information, the business appears to be a commercial-stage supplier of research tools and outsourced protein production services, not a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amid Biosciences.